Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy (original) (raw)
Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients
Hiroyuki Gatanaga
Virology, 2004
View PDFchevron_right
Rapid Screening of Phenotypic Resistance to Nevirapine by Direct Analysis of HIV Type 1 Reverse Transcriptase Activity in Plasma
Guillermo Rosales
AIDS Research and Human Retroviruses, 1999
View PDFchevron_right
Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors
Francesco Chiodo
International Journal of Antimicrobial Agents, 2003
View PDFchevron_right
Human Immunodeficiency Virus Mutagenesis during Antiviral Therapy: Impact of Drug-Resistant Reverse Transcriptase and Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors on Human Immunodeficiency Virus Type 1 Mutation Frequencies
Renxiang Chen
Journal of Virology, 2005
View PDFchevron_right
Transmission of Human Immunodeficiency Virus Type 1 Resistant to Nevirapine and Zidovudine
Allison Imrie
The Journal of Infectious Diseases, 1997
View PDFchevron_right
Distribution of K103N and/or Y181C HIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors
K. Hertogs
Journal of Antimicrobial Chemotherapy, 2001
View PDFchevron_right
N348I in the Connection Domain of HIV1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance
Viviane Lima
PLOS Medicine, 2007
View PDFchevron_right
High-Level Resistance to 3'Azido3'-Deoxythimidine due to a Deletion in the Reverse Transcriptase Gene of Human Immunodeficiency Virus Type 1
Tanima Sinha
Journal of Virology, 2000
View PDFchevron_right
Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
Shinichi Oka
Journal of Virology, 2008
View PDFchevron_right
Detection of HIV-1 Drug Resistance in Women Following Administration of a Single Dose of Nevirapine: Comparison of Plasma RNA to Cellular DNA by Consensus Sequencing and by Oligonucleotide Ligation Assay
Malee Techapornroong
Journal of Clinical Microbiology, 2010
View PDFchevron_right
Prevalence of Mutations Associated with Reduced Antiretroviral Drug Susceptibility among Human Immunodeficiency Virus Type 1 Seroconverters in the United States, 1993–1998
M. Gwinn
The Journal of Infectious Diseases, 2000
View PDFchevron_right
Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance
Paul Kellam
Journal of General Virology, 1994
View PDFchevron_right
Effect of Zidovudine Resistance Mutations on Virologic Response to Treatment with Zidovudine‐Lamivudine‐Ritonavir: Genotypic Analysis of Human Immunodeficiency Virus Type 1 Isolates from AIDS Clinical Trials Group Protocol 315
John Spritzler
The Journal of Infectious Diseases, 2000
View PDFchevron_right
Multiple Drug Resistance to Nucleoside Analogues and Nonnucleoside Reverse Transcriptase Inhibitors in an Efficiently Replicating Human Immunodeficiency Virus Type 1 Patient Strain
Philippe Hermans
Journal of Infectious Diseases, 1996
View PDFchevron_right
HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors
Beverly Sha
Antiviral therapy
View PDFchevron_right
Evolution of Human Immunodeficiency Virus Type 1 (HIV1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV1Infected Patients Switched to Antiretroviral Therapy without NNRTIs
Xavier Duval
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Emergence of Drug Resistance Mutations in Human Immunodeficiency Virus Type 2Infected Subjects Undergoing Antiretroviral Therapy
Kamal Mansinho
2000
View PDFchevron_right
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects
S. Rusconi
Journal of Antimicrobial Chemotherapy, 2002
View PDFchevron_right
Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
W. Owino-Ong’Or
Proceedings of the National Academy of Sciences of the United States of America, 2011
View PDFchevron_right
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside …
Stefan Sarafianos
Journal of …, 2008
View PDFchevron_right
Genotypic and Phenotypic Resistance Patterns of Human Immunodeficiency Virus Type 1 Variants with Insertions or Deletions in the Reverse Transcriptase (RT): Multicenter Study of Patients Treated with RT Inhibitors
ali mohammed
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
Miller V, de Bethune MP, Kober A, et al. Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride
K. Hertogs
Antimicrobial Agents and Chemotherapy
View PDFchevron_right
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen
Oliviero Bosco
AIDS, 2000
View PDFchevron_right
Multidrug-Resistant Human Immunodeficiency Virus Type 1 Strains Resulting from Combination Antiretroviral Therapy
Astrid Iversen
1996
View PDFchevron_right
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine
Paul Kellam
Proceedings of the National Academy of Sciences, 1992
View PDFchevron_right
Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies
Dennis Pearl, L. Gajary, L. Mansky
Journal of Virology, 2002
View PDFchevron_right
Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase Inhibitors
Salome Charalambous
Antimicrobial agents and chemotherapy, 2015
View PDFchevron_right
A Mutation in the 3' Region of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase (Y318F) Associated with Nonnucleoside Reverse Transcriptase Inhibitor Resistance
Zabrina Brumme
Journal of Virology, 2002
View PDFchevron_right
Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Peripheral Blood Mononuclear Cell Proviral DNA among Antiretroviral Treatment-Naive and Treatment-Experienced Patients from Pune, India
Johannes Pröll
AIDS Research and Human Retroviruses, 2007
View PDFchevron_right